Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Birchmeier-Kohler, Carmen Prof. Dr. (1) Chen, Wei Prof. Dr. (1) Daniel, Peter Prof. Dr. (1) Daumke, Oliver Prof. Dr. (1) Janz, Martin Dr. (8) Lusatis, Simone (1) Pezzutto, Antonio Prof. Dr. (1) Rocks, Oliver Dr. (1) Scheidereit, Claus Prof. Dr. (1) Selbach, Matthias Prof. Dr. (7) Wolf, Jana Prof. Dr. (1) (-) Mathas, Stephan Dr. (8) (-) Wollert-Wulf, Brigitte (4) (-) Biologie maligner Lymphome (10) Genetik und Genomik von Herz- Kreislauferkrankungen (1) Strukturbiologie Membran-assoziierter Prozesse (1) 1999 (1) 2000 (1) 2001 (1) 2002 (5) 2003 (1) 2004 (2) 2005 (2) (-) 2006 (4) (-) 2007 (3) 2008 (4) 2009 (3) 2010 (3) 2011 (4) 2012 (1) (-) 2013 (3) 2014 (3) 2015 (5) 2016 (2) 2017 (3) 2018 (1) 2019 (2) 2020 (2) 2021 (3) 2022 (4) 2023 (9) 2024 (1) 10 Ergebnisse: Active Filter: Mathas, Stephan Dr.Wollert-Wulf, BrigitteBiologie maligner Lymphome200620072013 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 15. Mai 2006 / Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas 01. Juli 2006 / Blood Chromosomal rearrangements involving the BCL3 locus are recurrent in classical Hodgkin and peripheral T-cell lymphoma J.I. Martin-Subero I. Wlodarska C. Bastard J.M. Picquenot J. Hoeppner M. Giefing W. Klapper R. Siebert S. Mathas S. Joos H. Stein B. Doerken 01. März 2007 / Hum Immunol Dendritic cell maturation stage determines susceptibility to the proteasome inhibitor bortezomib M. Subklewe K. Sebelin-Wulf C. Beier A. Lietz S. Mathas B. Doerken A. Pezzutto 01. Mai 2007 / Br J Haematol Loss of bHLH transcription factor E2A activity in primary effusion lymphoma confers resistance to apoptosis A. Lietz M. Janz M. Sigvardsson F. Jundt B. Doerken S. Mathas 01. Oktober 2007 / Hematol Oncol Clin North Am The pathogenesis of classical Hodgkin's lymphoma: a model for B-cell plasticity S. Mathas 15. März 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou 01. Februar 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken 02. April 2013 / Structure Structural insights into the mechanism of GTPase activation in the GIMAP family D. Schwefel B.S. Arasu S.F. Marino B. Lamprecht K. Köchert E. Rosenbaum J. Eichhorst B. Wiesner J. Behlke O. Rocks S. Mathas O. Daumke 23. Juli 2013 / Proc Natl Acad Sci U S A PTEN loss defines a PI3K/AKT pathway-dependent germinal center subtype of diffuse large B-cell lymphoma M. Pfeifer M. Grau D. Lenze S.S. Wenzel A. Wolf B. Wollert-Wulf K. Dietze H. Nogai B. Storek H. Madle B. Dörken M. Janz S. Dirnhofer P. Lenz M. Hummel A. Tzankov G. Lenz 26. September 2013 / Blood IκB-ζ controls the constitutive NF-κB target gene network and survival of ABC DLBCL H. Nogai S.S. Wenzel S. Hailfinger M. Grau E. Kaergel V. Seitz B. Wollert-Wulf M. Pfeifer A. Wolf M. Frick K. Dietze H. Madle A. Tzankov M. Hummel B. Dörken C. Scheidereit M. Janz P. Lenz M. Thome G. Lenz
15. Mai 2006 / Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas
01. Juli 2006 / Blood Chromosomal rearrangements involving the BCL3 locus are recurrent in classical Hodgkin and peripheral T-cell lymphoma J.I. Martin-Subero I. Wlodarska C. Bastard J.M. Picquenot J. Hoeppner M. Giefing W. Klapper R. Siebert S. Mathas S. Joos H. Stein B. Doerken
01. März 2007 / Hum Immunol Dendritic cell maturation stage determines susceptibility to the proteasome inhibitor bortezomib M. Subklewe K. Sebelin-Wulf C. Beier A. Lietz S. Mathas B. Doerken A. Pezzutto
01. Mai 2007 / Br J Haematol Loss of bHLH transcription factor E2A activity in primary effusion lymphoma confers resistance to apoptosis A. Lietz M. Janz M. Sigvardsson F. Jundt B. Doerken S. Mathas
01. Oktober 2007 / Hematol Oncol Clin North Am The pathogenesis of classical Hodgkin's lymphoma: a model for B-cell plasticity S. Mathas
15. März 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou
01. Februar 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken
02. April 2013 / Structure Structural insights into the mechanism of GTPase activation in the GIMAP family D. Schwefel B.S. Arasu S.F. Marino B. Lamprecht K. Köchert E. Rosenbaum J. Eichhorst B. Wiesner J. Behlke O. Rocks S. Mathas O. Daumke
23. Juli 2013 / Proc Natl Acad Sci U S A PTEN loss defines a PI3K/AKT pathway-dependent germinal center subtype of diffuse large B-cell lymphoma M. Pfeifer M. Grau D. Lenze S.S. Wenzel A. Wolf B. Wollert-Wulf K. Dietze H. Nogai B. Storek H. Madle B. Dörken M. Janz S. Dirnhofer P. Lenz M. Hummel A. Tzankov G. Lenz
26. September 2013 / Blood IκB-ζ controls the constitutive NF-κB target gene network and survival of ABC DLBCL H. Nogai S.S. Wenzel S. Hailfinger M. Grau E. Kaergel V. Seitz B. Wollert-Wulf M. Pfeifer A. Wolf M. Frick K. Dietze H. Madle A. Tzankov M. Hummel B. Dörken C. Scheidereit M. Janz P. Lenz M. Thome G. Lenz